{
  "id": 9033126,
  "title": "Telos chairman & CEO John Wood sells $389,411 in shares",
  "url": "https://urgent.news/2026/09/21/telos-chairman-ceo-john-wood-sells-389-411-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-21T23:31:12.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/telos-chairman--ceo-john-wood-sells-389411-in-shares-93CH-4909744"
  },
  "original_language": "en",
  "account": "John B. Wood, CEO and Chairman of Telos Corp (TLS), sold 96,151 shares of the company's common stock on September 21, 2026. The transaction valued at approximately $389,411 was executed at share prices fluctuating between $4.03 and $4.10. The weighted average price for these shares was $4.05, reflecting a decline from the stock's 52-week low of $3.79, a decrease of around 41% in the past year. Prior to this, Wood owned 5,378,962 shares directly, 1,505,867 shares indirectly through an LLC, and 196,893.39 shares indirectly via a 401(k) plan. Mr. Wood's shares were previously inaccurately reported as a purchase of 200,000 shares in 2022; in reality, these were held indirectly by an LLC managed by Wood and his spouse. The recent sale was made amid Telos's recent financial performance, which saw a 33% year-over-year revenue increase to $47.7 million in its second quarter, outpacing its guidance. However, the company lowered its third-quarter revenue guidance and projected full-year revenue downward, impacting investor sentiment as evidenced by the share price decline. D.A. Davidson assigned a Neutral rating with a price target of $4.00 on Telos following the update. Despite these mixed signals, Wood maintains a significant beneficial ownership in the company.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "BridgeBio Pharma CEO Neil Kumar sells $690,847 in shares",
        "url": "https://urgent.news/2026/09/21/bridgebio-pharma-ceo-neil-kumar-sells-690-847-in-shares",
        "published": "2026-09-21T22:46:13.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}